Platform Technology Partners’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,000
Closed -$10.9K 226
2023
Q2
$10.9K Hold
11,000
0.01% 208
2023
Q1
$7.69K Hold
11,000
﹤0.01% 209
2022
Q4
$9.02K Hold
11,000
﹤0.01% 204
2022
Q3
$11K Hold
11,000
0.01% 193
2022
Q2
$18K Hold
11,000
0.01% 196
2022
Q1
$32K Hold
11,000
0.02% 207
2021
Q4
$53K Buy
11,000
+1,000
+10% +$6.45K 0.02% 212
2021
Q3
$76K Hold
10,000
0.03% 216
2021
Q2
$75K Buy
+10,000
New +$77.1K 0.03% 245

Platform Technology Partners's SURF Position: Q3 2023 in Review

Platform Technology Partners sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 11,000 shares — an estimated $10.9K sold.

Platform Technology Partners first reported a position in SURF in Q2 2021 and held it in 9 quarters. The position peaked at $76K in Q3 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Platform Technology Partners reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Platform Technology Partners sold 11,000 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $10.9K.
  • Platform Technology Partners first reported a position in Surface Oncology, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • Platform Technology Partners's Surface Oncology, Inc. Common Stock position peaked at $76K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Platform Technology Partners's 13F filing for Q3 2023, filed 8 Nov 2023.